Clinical Trials Logo

Psoriasis Genital clinical trials

View clinical trials related to Psoriasis Genital.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05938361 Recruiting - Psoriasis of Scalp Clinical Trials

Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis

ZODIPSO
Start date: June 1, 2023
Phase:
Study type: Observational

Psoriasis is a chronic inflammatory disease that affects between 2% and 4% of the French population.Some specific localizations are more difficult to manage, such as the scalp, nails, genital region and palmoplantar localizations. Tildrakizumab, an anti-interleukin-23 (IL-23) monoclonal antibody, has demonstrated efficacy and safety in the treatment of patients with moderate to severe psoriasis. Real-life data on the efficacy of Tildrakizumab in unselected patients with these difficult-to-treat locations are still limited. The aim of the ZODIPSO study is to evaluate the efficacy and safety of Tildrakizumab in patients presented difficult to treat locations in psoriasis : nail, scalp, genital and palmoplantar. The main objective is to assess the overall response and the specific response to Tildrakizumab at these specific areas up to W52.

NCT ID: NCT04099979 Recruiting - Psoriasis Clinical Trials

A Pilot Study to Explore the Role of Gut Flora in Psoriasis

Start date: March 2, 2020
Phase:
Study type: Observational

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.